Groundbreaking Findings on Femoropopliteal Arterial Disease Revealed at VIVA 2026#USA#Las_Vegas#Concept_Medical#SirPAD_Study#Femoropopliteal_PAD
Groundbreaking Findings on Femoropopliteal Arterial Disease Revealed at VIVA 2026
The SirPAD study highlights significant results for patients with femoropopliteal arterial disease at VIVA 2026, presenting vital insights for effective treatment.
third-news.com
September 21, 2026 at 11:55 AM
Groundbreaking Findings on Femoropopliteal Arterial Disease Revealed at VIVA 2026#USA#Las_Vegas#Concept_Medical#SirPAD_Study#Femoropopliteal_PAD
New Insights into Femoropopliteal Peripheral Artery Disease from SirPAD Study at VIVA 2026 Conference#USA#Las_Vegas#Concept_Medical#MagicTouch_PTA#SirPAD_Study
New Insights into Femoropopliteal Peripheral Artery Disease from SirPAD Study at VIVA 2026 Conference
At the VIVA 2026 conference, the SirPAD study showcases significant findings on femoropopliteal artery disease treatments, enhancing patient outcomes.
third-news.com
September 21, 2026 at 11:10 AM
New Insights into Femoropopliteal Peripheral Artery Disease from SirPAD Study at VIVA 2026 Conference#USA#Las_Vegas#Concept_Medical#MagicTouch_PTA#SirPAD_Study
SirPAD Subgroup Study Highlights Innovative Treatment for Femoropopliteal PAD at VIVA 2026#United_States#Las_Vegas#Concept_Medical#MagicTouch_PTA#SirPAD_Study
SirPAD Subgroup Study Highlights Innovative Treatment for Femoropopliteal PAD at VIVA 2026
The SirPAD study at VIVA 2026 presents new insights on treating claudication due to femoropopliteal PAD, exploring the benefits of sirolimus-coated balloons.
third-news.com
September 21, 2026 at 8:24 AM
SirPAD Subgroup Study Highlights Innovative Treatment for Femoropopliteal PAD at VIVA 2026#United_States#Las_Vegas#Concept_Medical#MagicTouch_PTA#SirPAD_Study